LANXESS India Provides 1 Tonne Surface Disinfectant to Maharashtra Govt


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ LANXESS Logo
LANXESS India's Rely+On™ Virkon™ inactivates coronavirus quickly

Specialty chemicals company LANXESS recently donated its highly effective Rely+On™ Virkon™ disinfectant to the Maharashtra Government to help reduce cross contamination of COVID-19 in civic hospitals and other establishments across the state. The product is being delivered in two tranches of 500 kgs each to the Government of Maharashtra relief co-ordination center at the Haffkine Institute in Mumbai.

LANXESS India had recently donated 100 Kgs of the disinfectant to Thane Municipal Corporation (TMC) for use in civil hospitals and other establishments.LANXESS globally is also donating ten metric tonnes of the disinfectant to hospitals, authorities and public institutions in 13 countries around the world.

Rely+On™ Virkon™ inactivates coronavirus quickly

With regard to the current global Coronavirus situation, independent tests have proven that Rely+On™ Virkon™ quickly inactivates a closely related surrogate of the currently spreading coronavirus strain. From these tests it can be concluded that Rely+On™ Virkon™ would also be effective against SARS-CoV-2 which is causing the current COVID-19 epidemic.

The independent test results indicated that Rely+On™ Virkon™ achieved inactivation of the coronavirus strain at a 1:100 dilution rate with a 10-minute contact time. This corresponds to test conditions required by the U.S. Environmental Protection Agency (EPA) and proves the performance and suitability of Rely+On™ Virkon™ for practical use.

Rely+On™ Virkon™ is diluted for application and sprayed on hard surfaces and equipment. It can therefore help to reduce the risk of cross contamination from surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.

Neelanjan Banerjee, Vice Chairman and Managing Director, LANXESS India commented, "We feel energized to have been able to contribute significantly in the fight against COVID-19 by utilizing our product expertise. We have been able to quickly align our production and logistics capacities to arrange for Rely+On™ Virkon™ for the purpose of this contribution. We are committed to working closely with government authorities and establishments in fighting the spread of this disease."

Tags : #Lanxessindia #Coronavirus #Surfacedisinfectant #Maharashtragovt

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026